R
Robert Ford
Researcher at BioClinica
Publications - 23
Citations - 24285
Robert Ford is an academic researcher from BioClinica. The author has contributed to research in topics: Response Evaluation Criteria in Solid Tumors & Clinical trial. The author has an hindex of 12, co-authored 21 publications receiving 19000 citations. Previous affiliations of Robert Ford include Princeton University.
Papers
More filters
Journal ArticleDOI
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
Elizabeth Eisenhauer,P. Therasse,Jan Bogaerts,Lawrence H. Schwartz,Daniel J. Sargent,Robert Ford,Janet Dancey,S. Arbuck,S. Gwyther,Margaret M. Mooney,Larry Rubinstein,Lalitha K. Shankar,Lori E. Dodd,Robert M. Kaplan,Denis Lacombe,Jaap Verweij +15 more
TL;DR: The revised RECIST includes a new imaging appendix with updated recommendations on the optimal anatomical assessment of lesions, and a section on detection of new lesions, including the interpretation of FDG-PET scan assessment is included.
Journal ArticleDOI
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Lesley Seymour,Jan Bogaerts,Andrea Marie Perrone,Robert Ford,Lawrence H. Schwartz,Lawrence H. Schwartz,Sumithra J. Mandrekar,Nan Lin,Saskia Litière,Janet Dancey,Alice P. Chen,F. Stephen Hodi,Patrick Therasse,Otto S. Hoekstra,Lalitha K. Shankar,Jedd D. Wolchok,Marcus Ballinger,Marcus Ballinger,Marcus Ballinger,Caroline Caramella,Elisabeth G.E. de Vries +20 more
TL;DR: This guideline describes a standard approach to solid tumour measurements and definitions for objective change in tumour size for use in trials in which an immunotherapy is used and defines the minimum datapoints required from future trials to facilitate the compilation of a data warehouse to later validate iRECIST.
Journal ArticleDOI
RECIST 1.1—Update and clarification: From the RECIST committee
Lawrence H. Schwartz,Lawrence H. Schwartz,Saskia Litière,Elisabeth G.E. de Vries,Robert Ford,Stephen J. Gwyther,Sumithra J. Mandrekar,Lalitha K. Shankar,Jan Bogaerts,Alice P. Chen,Janet Dancey,Wendy Hayes,F. Stephen Hodi,Otto S. Hoekstra,Erich P. Huang,Nan Lin,Yan Liu,Patrick Therasse,Jedd D. Wolchok,Lesley Seymour +19 more
TL;DR: The purpose of this paper was to summarise the questions posed and the clarifications provided as an update to the 2009 publication of Response Evaluation Criteria in Solid Tumours.
Journal ArticleDOI
Evaluation of lymph nodes with RECIST 1.1.
Lawrence H. Schwartz,Jan Bogaerts,Robert Ford,Lalitha K. Shankar,P. Therasse,S. Gwyther,Elizabeth Eisenhauer +6 more
TL;DR: These standardised lymph node guidelines are designed to be easy to implement, focus target lesion measurements on lesions that are likely to be metastatic and prevent false progressions due to minimal change in size.
Journal ArticleDOI
RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.
Lawrence H. Schwartz,Lesley Seymour,Saskia Litière,Robert Ford,Stephen J. Gwyther,Sumithra J. Mandrekar,Lalitha K. Shankar,Jan Bogaerts,Alice P. Chen,Janet Dancey,Wendy Hayes,F. Stephen Hodi,Otto S. Hoekstra,Erich P. Huang,Nan Lin,Yan Liu,Patrick Therasse,Jedd D. Wolchok,Elisabeth G.E. de Vries +18 more
TL;DR: These are the commonly described modifications of RECIST, each of which is associated with different levels of evidence and validation, and the rationale for modifications should be considered.